-
Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo
de Jong, G., Bartels, L., Kedde, M., Verdegaal, E. M. E., Gillissen, M. A., Levie, S. E., Cercel, M. G., van Hal-van Veen, S. E., Fatmawati, C., van de Berg, D., Yasuda, E., Claassen, Y. B., Bakker, A. Q., van der Burg, S. H., Schotte, R., Villaudy, J., Spits, H., Hazenberg, M. D., van Helden, P. M. & Wagner, K., Jun 2021, In: Cancer Immunology, Immunotherapy. 70, 6, p. 1569-1581 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
A chemo-enzymatically linked bispecific antibody retargets T cells to a sialylated epitope on CD43 in acute myeloid leukemia
Bartels, L., de Jong, G., Gillissen, M. A., Yasuda, E., Kattler, V., Bru, C., Fatmawati, C., van Hal-van Veen, S. E., Cercel, M. G., Moiset, G., Bakker, A. Q., van Helden, P. M., Villaudy, J., Hazenberg, M. D., Spits, H. & Wagner, K., 2019, In: Cancer research. 79, 13, p. 3372-3382Research output: Contribution to journal › Article › Academic › peer-review
-
AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses
Gillissen, M. A., Kedde, M., De Jong, G., Moiset, G., Yasuda, E., Levie, S. E., Bakker, A. Q., Claassen, Y. B., Wagner, K., Böhne, M., Hensbergen, P. J., Speijer, D., Van Helden, P. M., Beaumont, T., Spits, H. & Hazenberg, M. D., 4 Jan 2018, In: Blood. 131, 1, p. 131-143 13 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
